CLINICAL_TRIALS
trial_result
· 2019-01-23
Clinical Trial Update: OCT-guided LALAK for KCN [NA]
Summary
A terminated clinical trial (NCT01901614) evaluated OCT-guided LALAK for Keratoconus. Results were posted on 2019-01-23.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oregon Health and Science University | Conditions: Corneal Opacity, Keratoconus | NA | Status: TERMINATED | Results posted: 2019-01-23